459 Results for "

PROTAC compound

" in MedChemExpress (MCE) Product Catalog:
Products (459)

459 Results for "PROTAC compound" in MCE Product Catalog:

Cat. No.: HY-151475
CAS No.: 3031442-96-0
Research Areas:  

Cancer

GID4 Ligand 1 (compound 88) is a cell-permeable and high-selective GID4 binder (IC50=5.4 μM; Kd=5.6 μM), binds to GID4 in cells (EC50=558 nM). GID4 Ligand 1 can be used for the synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-159015
Target:  

PROTACs

Research Areas:  

Cancer

SIAIS630120-NC is a negative control PROTAC compound synthesized using a methylated CRBN ligand, which serves as a control for SIAIS630120. SIAIS630120-NC lacks NAMPT degradation activity. SIAIS630120-NC exerts no cytotoxic effect on hematological tumor cells .
loading...
    loading...
Cat. No.: HY-160017
CAS No.: 2682112-09-8
Research Areas:  

Cancer

Pomalidomide-5'-C8-acid (Compound 3d') is an E3 ligase ligand-linker conjugate containing a Pomalidomide (HY-10984) based cereblon (CRBN) ligand and a linker. Pomalidomide-5'-C8-acid can be used in the synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-W005799
CAS No.: 939-69-5
Target:  

Ligands for E3 Ligase

Research Areas:  

Others

E3 ligase Ligand 80 (Compound S4) is an E3 ligase ligand that can be used in the recruitment of DCAF16 protein. E3 ligase Ligand 80 can be used to synthesis of PROTAC BRD4 degrader JQ1-JX5 (HY-183575) .
loading...
    loading...
Cat. No.: HY-150905
CAS No.: 2737283-20-2
Target:  

EGFR

Research Areas:  

Cancer

EGFR ligand-2 (compound C4), a covalent EGFR ligand, is a EGFR mutant inhibitor with IC50s of 21 nM and 48 nM for EGFR L858R and EGFR L858R/T790M, respectively. EGFR ligand-2 can be used to synthesize PROTAC .
loading...
    loading...
Cat. No.: HY-159006
CAS No.: 65823-65-6
CYP1B1 ligand 3 (Compound A1) is a selective inhibitor for cytochrome P450 enzyme CYP1B1 with an IC50 of 11.9 nM. CYP1B1 ligand 3 can be utilized for the synthesis of PROTAC CYP1B1 degrader-2 (HY-158429) .
loading...
    loading...
Cat. No.: HY-159087
Target:  

PROTACs

Research Areas:  

Cancer

RGB110 (Compound 10d) is a PROTAC inhibitor for D-dopachrome tautomerase with an IC50 of 5.9 μM. RGB110 causes no degradation of D-DT. (Pink: ligand for target protein (HY-159164); Black: linker (HY-W125017); Blue: ligand for E3 ligase CRBN (HY-10984))
loading...
    loading...
Cat. No.: HY-159452
CAS No.: 2568273-68-5
Target:  

PROTACs

Research Areas:  

Cancer

SMARCA2/4-degrader-1 (compound I-430) is a PROTAC degrader targeting SMARCA2 and SMARCA4; it degrades SMARCA2/4 proteins in A549 cells with the DC50s <100 nM, and the maximum degradation rate (Dmax%) >90 after 24 h of treatment .
loading...
    loading...
Cat. No.: HY-184542
CAS No.: 1693735-07-7
Research Areas:  

Others

HSF1 ligand-1 (compound 18) is a ligand for heat shock transcription factor HSF1, as well as a binder for the high-affinity nuclear protein pirin, with an SPR Kd of 44 nM. HSF1 ligand-1 can be used to prepare HSF1-targeted PROTAC degrader (HY-122653) .
loading...
    loading...
Cat. No.: HY-161960
EP300/CBP ligand 2 (compound S19) is a ligand targeting the bromodomain of CREB binding protein (CBP) and E1A-associated protein (EP300). EP300/CBP ligand 2 can be used as a target protein ligand in the PROTAC structure, and can be coupled to the E3 ubiquitin ligase ligand through the PTOTAC Linker to synthesize PROTAC molecules with degradation effects. For example, EP300/CBP ligand 2 can be coupled with the conjugate (E3 ubiquitin enzyme ligand + Linker) Thalidomide-NH-C10-Boc (HY-161961) to produce the PROTAC molecule dCE-2 (HY-161958) .
loading...
    loading...
Cat. No.: HY-155560
CAS No.: 2093387-55-2
Synonyms: Pomalidomide 4'-alkylC7-amine
Research Areas:  

Cancer

Pomalidomide-C7-NH2 (Pomalidomide 4'-alkylC7-amine) (Compound 24g) is an E3 Ligase Ligand-Linker Conjugates consisting of Pomalidomide (HY-10984) and a linker. Pomalidomide-C7-NH2 can be used for synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-169357
Research Areas:  

Cancer

Acepromazine-1-piperazinepropanamine (compound 10) is a synthesized E3 ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugate) that incorporates a TRIM21 ligand and a linker. Acepromazine-1-piperazinepropanamine can be connected to the target protein ligand to form a PROTAC molecule, TrimTAC1 (HY-169355) .
loading...
    loading...
Cat. No.: HY-169357B
Research Areas:  

Cancer

Acepromazine-1-piperazinepropanamine dihydrochloride (compound 10) is a synthesized E3 ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugate) that incorporates a TRIM21 ligand and a linker. Acepromazine-1-piperazinepropanamine dihydrochloride can be connected to the target protein ligand to form a PROTAC molecule, TrimTAC1 (HY-169355) .
loading...
    loading...
Cat. No.: HY-172375
CAS No.: 2379572-21-9
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 170 (Compound I) exhibits anti-proliferative activity in non-Hodgkin's lymphoma cell SU-DHL-4 with IC50 < 0.2 μM. E3 Ligase Ligand-linker Conjugate 170 is the conjugate composed of an E3 ligase ligand and a linker that can be used for PROTAC synthesis .
loading...
    loading...
Cat. No.: HY-186270
CAS No.: 3050872-68-6
Research Areas:  

Others

CBP/BRD4-IN-1 (Compound 22) is a dual bromodomain inhibitor of CBP and BRD4 BD1, with IC50 values of 1.2 μM and 3.2 μM, respectively. CBP/BRD4-IN-1 serves as a target protein ligand for the synthesis of PROTACs, such as MS8847N1 (HY-18626) .
loading...
    loading...
Cat. No.: HY-W800760
CAS No.: 2839806-94-7
Research Areas:  

Cancer

(S, R, S)-AHPC-PEG6-Tos is a combination of a von Hippel-Lindau (VHL)-recruiting ligand and PEGylated crosslinker with a tosyl group. The tosyl group is a good leaving group for nucleophilic substitution reactions. (S, R, S)-AHPC-PEG2-Tos is useful for synthesis of PROTAC compounds and molecules for targeted protein degradation.
loading...
    loading...
Cat. No.: HY-174314
CAS No.: 2845188-22-7
WZH-15-125 is a potent ALK inhibitor. WZH-15-125 can effectively overcome drug resistance, especially compound ALK mutations. WZH-15-125 has an IC50 of 101.7 nM for the highly refractory G1202R/L1196M mutation that is resistant to Lorlatinib (HY-12215). WZH-15-125 can be used as a PROTAC target protein ligand to synthesize PROTAC WZH-17-002 (HY-174315). WZH-15-125 can be used in the research of non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-130853
CAS No.: 2097509-40-3
Purity:  98.37%
Thalidomide-NH-PEG2-C2-NH-Boc is a synthesized?E3 ligase ligand-linker conjugate?that incorporates the?Thalidomide?based cereblon ligand and a PEG linker used for dBRD9 (compound 6) synthesis. dBRD9 is a selective BRD9 probe PROTAC degrader for the study of BAF complex biology .
loading...
    loading...
Cat. No.: HY-147192
CAS No.: 2098799-79-0
Research Areas:  

Cancer

(S,R,S)-AHPC-O-PEG1-propargyl (Compound 10b) is an E3 ligand for the synthesis of PROTAC . (S,R,S)-AHPC-O-PEG1-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-161495
CAS No.: 3040120-71-3
CBP/p300 ligand 4 (Compound 4) is an orally active inhibitor for CBP/p300 bromodomain, with IC50 of 91.4 nM. CBP/p300 ligand 4 serves as a ligand for target protein XYD190 (HY-161495). XYD190 is a PROTAC degrader for CBP/p300 .
loading...
    loading...